CRA Senior Consultant, Dr. James R. Kearl, recently testified for Plaintiff, Complete Genomics, Inc. (CGI), in a Delaware Federal Court about damages in a patent infringement trial dealing with DNA sequencing. The jury returned a verdict in favor of CGI deciding that Defendant, Illumina, Inc., willfully infringed CGI’s patents and awarded the precise number of Dr. Kearl’s damages: $333.8 million. Dr. Kearl was assisted by the CRA team in Salt Lake City, including VP, Dr. Greg Adams, Principal, Dr. Steven Waters, and CRA Associates, Todd Lewis, Anna Cvetko, and Mason Fields. Dr. Kearl was retained by the law firm Quinn Emanuel Urquhart & Sullivan LLP.
Trade Secrets Monetary Remedies Commentary
The rules for what money a successful trade secret claimant can recover are easy to state but often difficult to apply. The Sedona Conference’s Working Group...